The pharmaceutical industry is pushing back against Governor Cuomo's prescription drug price control proposal, arguing that it would lead to cuts in research. And they are pointing the finger at insurance companies and companies known as pharmacy benefit managers for the high costs paid by patients. Peter Pitts is a former FDA Associate Commissioner for External Relations and is now President of the Center for Medicine in the Public Interest.
Pharmaceutical Industry Raises Issue with Cuomo's Drug Price Control Proposal
RECENT NEWS
Truth vs. Tort
New litigation alleging preterm infant formula and human milk fortifiers cause NEC distorts the facts and ignores what th... Read more
New CMPI Book: And Nothing But the Truth
Healthcare evolution, in technology and policy, is a never-ending parade of complicated and contradictory truths. This bo... Read more
Tort bar’s newest collateral damage: Preterm babies
Lawsuits allege links between intestinal disease, infant formula and human milk fortifiers... Read more